Research programme: quinolinylmethoxyaryl compounds - Merckle
Alternative Names: COX-5-LOX inhibitors research programme - Merckle; Dual cyclo-oxygenase/5-lipoxygenase inhibitors research programme - MerckleLatest Information Update: 05 Apr 2007
At a glance
- Originator Merckle
- Class
- Mechanism of Action 5-lipoxygenase inhibitors; Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 05 Apr 2007 Discontinued - Preclinical for Inflammation in Germany (PO)
- 05 Sep 2002 This programme is still in active development
- 07 Sep 1999 New profile